---
title: "Xishan Science&Technology has completed its buyback, spending a total of 197 million yuan to repurchase 6.296% of its shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232397944.md"
description: "According to the announcement from Xishan Science&Technology on the Zhitong Finance APP, the company has completed its share repurchase, having repurchased a total of 3.1245 million shares through centralized bidding, accounting for 6.2960% of the company's total share capital, with a total payment of RMB 197 million (excluding transaction fees)"
datetime: "2025-03-19T10:56:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232397944.md)
  - [en](https://longbridge.com/en/news/232397944.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232397944.md)
generator: "portal-rs"
---

# Xishan Science&Technology has completed its buyback, spending a total of 197 million yuan to repurchase 6.296% of its shares

According to the Zhitong Finance APP, Xishan Science&Technology (688576.SH) announced that the company has completed its share repurchase, having repurchased a total of 3.1245 million shares through centralized bidding, accounting for 6.2960% of the company's total share capital, with a total payment of RMB 197 million (excluding transaction fees)

### Related Stocks

- [688576.CN](https://longbridge.com/en/quote/688576.CN.md)

## Related News & Research

- [KINGSOFT  Interim Net Profit Up 100.8% YoY to RMB1.639 Billion; No Interim Dividend](https://longbridge.com/en/news/296417569.md)
- [Nurture plans new production site as Oosterbeek facility hits capacity limits](https://longbridge.com/en/news/296582570.md)
- [PEB: Draft Medicare coverage for Cxbladder tests marks a pivotal step toward renewed growth](https://longbridge.com/en/news/296426151.md)
- [Britain's JD Sports cuts profit outlook as U.S. sales slump](https://longbridge.com/en/news/296444248.md)
- [Alma News Media joins SPUR coalition on AI licensing standards for publishers](https://longbridge.com/en/news/296579604.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**